Steve Perry

916 total citations
18 papers, 737 citations indexed

About

Steve Perry is a scholar working on Molecular Biology, Pharmacology and Biochemistry. According to data from OpenAlex, Steve Perry has authored 18 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Pharmacology and 6 papers in Biochemistry. Recurrent topics in Steve Perry's work include Eicosanoids and Hypertension Pharmacology (6 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Fatty Acid Research and Health (5 papers). Steve Perry is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (6 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Fatty Acid Research and Health (5 papers). Steve Perry collaborates with scholars based in United States, Chile and Canada. Steve Perry's co-authors include Theodore R. Holman, Netra Joshi, Michael Holinstat, Ajit Jadhav, Anton Simeonov, David J. Maloney, Lena Schultz, John T. Pinto, Domenico Praticò and Amit Kumar and has published in prestigious journals such as PLoS ONE, Biochemistry and Annals of Neurology.

In The Last Decade

Steve Perry

18 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Perry United States 13 337 173 124 123 120 18 737
Peter J. Bungay United Kingdom 18 428 1.3× 188 1.1× 66 0.5× 60 0.5× 64 0.5× 35 948
Russell D. Klein United States 20 524 1.6× 106 0.6× 305 2.5× 138 1.1× 246 2.0× 24 1.1k
Toshiya Tamura Japan 19 559 1.7× 145 0.8× 37 0.3× 74 0.6× 90 0.8× 53 969
Gi‐Ryang Kweon South Korea 17 478 1.4× 32 0.2× 112 0.9× 147 1.2× 243 2.0× 26 1.0k
Akiko Amagata United States 8 357 1.1× 109 0.6× 139 1.1× 45 0.4× 88 0.7× 10 575
María M. Facchinetti Argentina 18 879 2.6× 57 0.3× 93 0.8× 53 0.4× 140 1.2× 42 1.1k
Maureen O. Ripple United States 16 552 1.6× 119 0.7× 40 0.3× 83 0.7× 132 1.1× 21 895
Baoxia Liang China 14 297 0.9× 96 0.6× 64 0.5× 31 0.3× 90 0.8× 26 769
Guy Miller United States 12 620 1.8× 116 0.7× 17 0.1× 94 0.8× 87 0.7× 27 945
Jih‐Lie Tseng United States 13 248 0.7× 66 0.4× 56 0.5× 53 0.4× 34 0.3× 26 569

Countries citing papers authored by Steve Perry

Since Specialization
Citations

This map shows the geographic impact of Steve Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Perry more than expected).

Fields of papers citing papers by Steve Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Perry. The network helps show where Steve Perry may publish in the future.

Co-authorship network of co-authors of Steve Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Perry. A scholar is included among the top collaborators of Steve Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Perry. Steve Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yamaguchi, Adriana, Benjamin E. Tourdot, Steve Perry, et al.. (2023). Fatty acids negatively regulate platelet function through formation of noncanonical 15‐lipoxygenase‐derived eicosanoids. Pharmacology Research & Perspectives. 11(1). e01056–e01056. 7 indexed citations
2.
Perry, Steve, et al.. (2022). Structural basis for altered positional specificity of 15-lipoxygenase-1 with 5S-HETE and 7S-HDHA and the implications for the biosynthesis of resolvin E4. Archives of Biochemistry and Biophysics. 727. 109317–109317. 4 indexed citations
3.
Tsai, Wan‐Chen, Nathaniel C. Gilbert, Steve Perry, et al.. (2021). Kinetic and structural investigations of novel inhibitors of human epithelial 15-lipoxygenase-2. Bioorganic & Medicinal Chemistry. 46. 116349–116349. 19 indexed citations
4.
Perry, Steve, Thomas Horn, Benjamin E. Tourdot, et al.. (2020). Role of Human 15-Lipoxygenase-2 in the Biosynthesis of the Lipoxin Intermediate, 5S,15S-diHpETE, Implicated with the Altered Positional Specificity of Human 15-Lipoxygenase-1. Biochemistry. 59(42). 4118–4130. 14 indexed citations
5.
Freedman, Cody J., Benjamin E. Tourdot, Chakrapani Kalyanaraman, et al.. (2020). Biosynthesis of the Maresin Intermediate, 13S,14S-Epoxy-DHA, by Human 15-Lipoxygenase and 12-Lipoxygenase and Its Regulation through Negative Allosteric Modulators. Biochemistry. 59(19). 1832–1844. 28 indexed citations
6.
Perry, Steve, Chakrapani Kalyanaraman, Benjamin E. Tourdot, et al.. (2020). 15-Lipoxygenase-1 biosynthesis of 7S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5. Journal of Lipid Research. 61(7). 1087–1103. 38 indexed citations
7.
Karuppagounder, Saravanan S., Yingxin Chen, David Brand, et al.. (2018). N‐acetylcysteine targets 5 lipoxygenase‐derived, toxic lipids and can synergize with prostaglandin E2 to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice. Annals of Neurology. 84(6). 854–872. 238 indexed citations
8.
Perry, Steve, et al.. (2015). An extracellular biochemical screen reveals that FLRTs and Unc5s mediate neuronal subtype recognition in the retina. eLife. 4. e08149–e08149. 42 indexed citations
9.
Mascayano, Carolina, et al.. (2014). Enzymatic Studies of Isoflavonoids as Selective and Potent Inhibitors of Human Leukocyte 5‐Lipo‐Oxygenase. Chemical Biology & Drug Design. 86(1). 114–121. 10 indexed citations
10.
Luci, Diane K., Adam Yasgar, Netra Joshi, et al.. (2014). Synthesis and Structure–Activity Relationship Studies of 4-((2-Hydroxy-3-methoxybenzyl)amino)benzenesulfonamide Derivatives as Potent and Selective Inhibitors of 12-Lipoxygenase. Journal of Medicinal Chemistry. 57(2). 495–506. 65 indexed citations
11.
Luci, Diane K., Adam Yasgar, Netra Joshi, et al.. (2014). Discovery of ML355, a Potent and Selective Inhibitor of Human 12-Lipoxygenase. 17 indexed citations
12.
Rai, Ganesha, Netra Joshi, Steve Perry, et al.. (2014). Discovery of ML351, a Potent and Selective Inhibitor of Human 15-Lipoxygenase-1. Europe PMC (PubMed Central). 12 indexed citations
13.
Rai, Ganesha, Netra Joshi, Joo Eun Jung, et al.. (2014). Potent and Selective Inhibitors of Human Reticulocyte 12/15-Lipoxygenase as Anti-Stroke Therapies. Journal of Medicinal Chemistry. 57(10). 4035–4048. 86 indexed citations
14.
Rai, Ganesha, Andrew G. S. Warrilow, Steve Perry, et al.. (2013). Discovery of a Novel Dual Fungal CYP51/Human 5-Lipoxygenase Inhibitor: Implications for Anti-Fungal Therapy. PLoS ONE. 8(6). e65928–e65928. 18 indexed citations
15.
Mascayano, Carolina, et al.. (2013). In Vitro Study of Isoflavones and Isoflavans as Potent Inhibitors of Human 12‐ and 15‐Lipoxygenases. Chemical Biology & Drug Design. 82(3). 317–325. 12 indexed citations
16.
17.
Flatt, Patricia M., Xiumei Wu, Steve Perry, & Taifo Mahmud. (2013). Genetic Insights into Pyralomicin Biosynthesis in Nonomuraea spiralis IMC A-0156. Journal of Natural Products. 76(5). 939–946. 40 indexed citations
18.
Kenyon, Victor, Ganesha Rai, Ajit Jadhav, et al.. (2011). Discovery of Potent and Selective Inhibitors of Human Platelet-Type 12- Lipoxygenase. Journal of Medicinal Chemistry. 54(15). 5485–5497. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026